SatyaDx

Transforming Cancer Treatment Through Biomarker Innovation

Meet Dr. Dixon

The SatyaDx Platform

SatyaDx patented NOHA as a biomarker to determine the effectiveness of a range of cancer treatments, including chemotherapy.

Satya Dx is a pioneer in vitro diagnostics (IVD) for precise cancer treatment monitoring and personalized medicine.

Service